Recombinant multi-species PNLIP/Pancreatic Lipase protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PNLIP/Pancreatic Lipase protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the lipase family of proteins. The encoded enzyme is secreted by the pancreas and hydrolyzes triglycerides in the small intestine, and is essential for the efficient digestion of dietary fats. Inhibition of the encoded enzyme may prevent high-fat diet-induced obesity in mice and result in weight loss in human patients with obesity. Mutations in this gene cause congenital pancreatic lipase deficiency, a rare disorder characterized by steatorrhea. [provided by RefSeq, Jul 2016]
The Alternative Names of target: 1810007A24Rik,PANLI,PL,PNLIP,PNLIPD,PTL,Pancreatic Lipase,Pancreatic lipase,Pancreatic triacylglycerol lipase,Pnlip

Target products collectionGo to PNLIP/Pancreatic Lipase products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T94309-Ag-1/ GM-Tg-hg-T94309-Ag-2 Human PNLIP/Pancreatic Lipase protein Human
GM-Tg-rg-T94309-Ag-1/ GM-Tg-rg-T94309-Ag-2 Rat PNLIP/Pancreatic Lipase protein Rat
GM-Tg-mg-T94309-Ag-1/ GM-Tg-mg-T94309-Ag-2 Mouse PNLIP/Pancreatic Lipase protein Mouse
GM-Tg-cynog-T94309-Ag-1/ GM-Tg-cynog-T94309-Ag-2 Cynomolgus/Rhesus macaque PNLIP/Pancreatic Lipase protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T94309-Ag-1/ GM-Tg-felg-T94309-Ag-2 Feline PNLIP/Pancreatic Lipase protein Feline
GM-Tg-cang-T94309-Ag-1/ GM-Tg-cang-T94309-Ag-2 Canine PNLIP/Pancreatic Lipase protein Canine
GM-Tg-bovg-T94309-Ag-1/ GM-Tg-bovg-T94309-Ag-2 Bovine PNLIP/Pancreatic Lipase protein Bovine
GM-Tg-equg-T94309-Ag-1/ GM-Tg-equg-T94309-Ag-2 Equine PNLIP/Pancreatic Lipase protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T94309-Ag-1/ GM-Tg-hg-T94309-Ag-2; GM-Tg-rg-T94309-Ag-1/ GM-Tg-rg-T94309-Ag-2;
GM-Tg-mg-T94309-Ag-1/ GM-Tg-mg-T94309-Ag-2; GM-Tg-cynog-T94309-Ag-1/ GM-Tg-cynog-T94309-Ag-2;
GM-Tg-felg-T94309-Ag-1/ GM-Tg-felg-T94309-Ag-2; GM-Tg-cang-T94309-Ag-1/ GM-Tg-cang-T94309-Ag-2;
GM-Tg-bovg-T94309-Ag-1/ GM-Tg-bovg-T94309-Ag-2; GM-Tg-equg-T94309-Ag-1/ GM-Tg-equg-T94309-Ag-2
Products Name PNLIP/Pancreatic Lipase protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PNLIP/Pancreatic Lipase
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PNLIP/Pancreatic Lipase protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.